Current use of vasopressors in septic shock by T.W.L. Scheeren et al.
Current use of vasopressors in septic shock
Submitted by Beatrice Guillaumat on Wed, 02/27/2019 - 09:51
Titre Current use of vasopressors in septic shock
Type de
publication Article de revue
Auteur
Scheeren, Thomas WL [1], Bakker, Jan [2], De Backer, Daniel [3], Annane, Djillali [4],
Asfar, Pierre [5], Boerma, E. Christiaan [6], Cecconi, Maurizio [7], Dubin, Arnaldo [8],
Dünser, Martin W [9], Duranteau, Jacques [10], Gordon, Anthony C [11], Hamzaoui,
Olfa [12], Hernández, Glenn [13], Leone, Marc [14], Levy, Bruno [15], Martin, Claude
[16], Mebazaa, Alexandre [17], Monnet, Xavier [18], Morelli, Andrea [19], Payen,
Didier [20], Pearse, Rupert [21], Pinsky, Michael R [22], Radermacher, Peter [23],
Reuter, Daniel [24], Saugel, Bernd [25], Sakr, Yasser [26], Singer, Mervyn [27],
Squara, Pierre [28], Vieillard-Baron, Antoine [29], Vignon, Philippe [30], Vistisen,
Simon T [31], van der Horst, Iwan CC [32], Vincent, Jean-Louis [33], Teboul, Jean-
Louis [34]
Editeur BMC
Type Article scientifique dans une revue à comité de lecture
Année 2019
Langue Anglais





revue Annals of intensive care
ISSN 2110-5820
Mots-clés Arterial blood pressure [35], Norepinephrine [36], Resuscitation [37], Sepsis [38],septic shock [39], Shock [40], Vasoactive agonists [41], Vasopressor [42]
Résumé en
anglais
BACKGROUND: Vasopressors are commonly applied to restore and maintain blood
pressure in patients with sepsis. We aimed to evaluate the current practice and
therapeutic goals regarding vasopressor use in septic shock as a basis for future
studies and to provide some recommendations on their use.
METHODS: From November 2016 to April 2017, an anonymous web-based survey on
the use of vasoactive drugs was accessible to members of the European Society of
Intensive Care Medicine (ESICM). A total of 17 questions focused on the profile of
respondents, triggering factors, first choice agent, dosing, timing, targets, additional
treatments, and effects of vasopressors. We investigated whether the answers
complied with current guidelines. In addition, a group of 34 international ESICM
experts was asked to formulate recommendations for the use of vasopressors based on
6 questions with sub-questions (total 14).
RESULTS: A total of 839 physicians from 82 countries (65% main specialty/activity
intensive care) responded. The main trigger for vasopressor use was an insufficient
mean arterial pressure (MAP) response to initial fluid resuscitation (83%). The first-
line vasopressor was norepinephrine (97%), targeting predominantly a
MAP > 60-65 mmHg (70%), with higher targets in patients with chronic arterial
hypertension (79%). The experts agreed on 10 recommendations, 9 of which were
based on unanimous or strong (≥ 80%) agreement. They recommended not to delay
vasopressor treatment until fluid resuscitation is completed but rather to start with
norepinephrine early to achieve a target MAP of ≥ 65 mmHg.
CONCLUSION: Reported vasopressor use in septic shock is compliant with
contemporary guidelines. Future studies should focus on individualized treatment
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